SCHEMBL12417679

SCHEMBL12417679

Cc1csc(NC(=O)c2c(O)cc(C)n(C)c2=O)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.51
RAB9A P51151 12/20 0.51
NPC1 O15118 11/20 0.51
HPGD P15428 4/20 0.51
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 2/20 0.51
TP53 P04637 1/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
HSD17B10 Q99714 1/20 0.51
RCE1 Q9Y256 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SMN1; SMN2 Q16637 5/20 0.49
POLB P06746 2/20 0.49
PKM P14618 1/20 0.49
KMT2A Q03164 2/20 0.48
RECQL P46063 1/20 0.47
MEN1 O00255 1/20 0.46
LMNA P02545 1/20 0.46
GRM5 P41594 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1891491 0.86 SMN1; SMN2 (0.51) MAPTRAB9ANPC1ALDH1A1KDM4E
SCHEMBL1889947 0.80 RAB9A (0.51) MAPTRAB9ANPC1HPGDALDH1A1
SCHEMBL1888774 0.80 RAB9A (0.51) MAPTRAB9ANPC1HPGDALDH1A1
SCHEMBL1891165 0.80 RAB9A (0.51) RAB9ANPC1HPGDALDH1A1KDM4E
SCHEMBL1893161 0.79 RAB9A (0.52) MAPTRAB9ANPC1ALDH1A1TP53
SCHEMBL1890247 0.78 SMN1; SMN2 (0.49) MAPTRAB9ANPC1HPGDALDH1A1
SCHEMBL1893447 0.78 AHR (0.51) RAB9ANPC1HPGDALDH1A1SMN1; SMN2
SCHEMBL1886903 0.77 RAB9A (0.48) MAPTRAB9ANPC1ALDH1A1KDM4E
SCHEMBL12508094 0.76 RAB9A (0.55) RAB9ANPC1SMN1; SMN2POLBPKM
SCHEMBL1892597 0.75 RAB9A (0.47) MAPTRAB9ANPC1HPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304437-B2 Carboxamide compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-11-06 US disclosed
US-20110172276-A1 CARBOXAMIDE COMPOUND AND USE OF THE SAME ARIMORI SADAYUKI 2011-07-14 US disclosed
US-7935716-B2 Carboxamide compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-05-03 US disclosed
US-20090076063-A1 Carboxamide compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-03-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090076063-A1 Carboxamide compound and use of the same CBR3, SIRT2, SIRT1 MAPT 3161/4885RAB9A 1024/4885NPC1 1710/4885
US-20110172276-A1 CARBOXAMIDE COMPOUND AND USE OF THE SAME CBR3, SIRT2, SIRT1 MAPT 3161/4885RAB9A 1024/4885NPC1 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.